0 Commentaires
0 Parts
889 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
Adalimumab Market Strengthens with Expanding Autoimmune Disease Treatment Demand" According to the latest report published by Data Bridge Market Research, the Adalimumab Market CAGR Value The global adalimumab market size was valued at USD 22.09 billion in 2025 and is expected to reach USD 33.39 billion by 2033, at a CAGR of 5.30% during the forecast period Salient attributes used while forming an influential Adalimumab...0 Commentaires 0 Parts 322 Vue 0 Aperçu
-
Polymyositis Treatment Market Progresses with Advances in Autoimmune Disease Management" According to the latest report published by Data Bridge Market Research, the Polymyositis Treatment Market CAGR Value Data Bridge Market Research analyses a growth rate in the polymyositis treatment market in the forecast period 2022-2029. The expected CAGR of polymyositis treatment market is tend to be around 3% in the mentioned forecast period. A number of aspects that are...0 Commentaires 0 Parts 199 Vue 0 Aperçu
-
Why Is Ustekinumab Market Expanding Across Autoimmune Disease Treatment Applications?According to the latest report published by Data Bridge Market Research, the Ustekinumab Market CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Ustekinumab Market report contains most-detailed market segmentation, systematic analysis of...0 Commentaires 0 Parts 857 Vue 0 Aperçu
-
What’s Accelerating Adoption in the Global Ustekinumab Market for Autoimmune Care?Executive Summary Ustekinumab Market Size and Share: Global Industry Snapshot CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Businesses can depend with confidence upon this superior Ustekinumab Market report to bring about an utter success. An...0 Commentaires 0 Parts 2KB Vue 0 Aperçu